Investing in Innovation to Treat Chronic Disease
Published in
1 min readAug 3, 2016
BioTechnology is a very important sector within the U.S. economy, employing over 100,000 people with revenues of Biotech firms exceeding $80 billion. Continued investment and innovation in this sector is necessary to reduce the economic and societal burden that chronic disease have.
Learn more about this important sector of our economy from Members of Congress and BioTechnology industry analysts below:
